Back
Cidara Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
69
CDTX
Cidara Therapeutics
Last Price:
$52.27
Seasonality Move:
-8.55%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Cidara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.84 | Buy |
20-day SMA: | 43.89 | Buy |
50-day SMA: | 31.32 | Buy |
200-day SMA: | 22.05 | Buy |
8-day EMA: | 50.71 | Buy |
20-day EMA: | 44.77 | Buy |
50-day EMA: | 35.38 | Buy |
200-day EMA: | 24.24 | Buy |
Cidara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.65 | Buy |
Relative Strength Index (14 RSI): | 69.93 | Buy |
Chaikin Money Flow: | -523409 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.46 - 52.72) | Buy |
Bollinger Bands (100): | (15.83 - 36.63) | Buy |
Cidara Therapeutics Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 51.50 while CDTX 8-day simple moving average is 50.84, which is a Buy signal.
-
The stock price of CDTX is 51.50 while Cidara Therapeutics 20-day SMA is 43.89, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 31.32 while CDTX share price is 51.50, making it a Buy technically.
-
CDTX stock price is 51.50 and Cidara Therapeutics 200-day simple moving average is 22.05, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $51.50. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
1.1B
Price in USD:
51.50
Share Volume:
701.6K
Cidara Therapeutics 52-Week Range
52-Week High:
56.83
52-Week Low:
10.14
Buy
69
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 51.50 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 51.50 while CDTX 8-day exponential moving average is 50.71, which is a Buy signal.
-
The stock price of CDTX is 51.50 while Cidara Therapeutics 20-day EMA is 44.77, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 35.38 while CDTX share price is 51.50, making it a Buy technically.
-
CDTX stock price is 51.50 and Cidara Therapeutics 200-day simple moving average is 24.24, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 6.65, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 69.93, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (27.46 - 52.72), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (15.83 - 36.63), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.